US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Lucid Diagnostics Inc. - Common Stock
(NQ:
LUCD
)
0.6273
-0.0075 (-1.18%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lucid Diagnostics Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
March 30, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From
PAVmed Inc.
Via
Business Wire
Analyst Ratings For Lucid Diagnostics
↗
December 27, 2021
Lucid Diagnostics (NASDAQ:LUCD) has observed the following analyst ratings ...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
March 29, 2022
BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.
Via
Benzinga
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 28, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...
Via
Benzinga
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
March 24, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 02, 2022
Gainers Syros Pharmaceuticals (NASDAQ:SYRS
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 19, 2022
Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
January 19, 2022
Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
↗
January 19, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
January 14, 2022
Gainers Avinger (NASDAQ:AVGR) stock moved...
Via
Benzinga
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
January 12, 2022
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
10 Low-Float Penny Stocks for Steel-Gutted Investors
↗
January 11, 2022
If you’re willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 10, 2022
Gainers Inari Medical (NASDAQ:NARI) stock...
Via
Benzinga
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
January 06, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
34 Stocks Moving In Monday's Mid-Day Session
↗
December 27, 2021
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
December 28, 2021
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 27, 2021
Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million...
Via
Benzinga
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
December 01, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
61 Biggest Movers From Yesterday
↗
November 18, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...
Via
Benzinga
Topics
Initial Public Offering
42 Stocks Moving In Wednesday's Mid-Day Session
↗
November 17, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...
Via
Benzinga
Topics
Initial Public Offering
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2021
From
Lucid Diagnostics Inc. PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
November 16, 2021
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
November 11, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
↗
November 08, 2021
Upgrades For Nektar Therapeutics (NASDAQ:
Via
Benzinga
< Previous
1
2
3
4
5
Next >
